Thirty-day hospital revisits after prostate brachytherapy: who is at risk?

BACKGROUND: Transperineal prostate brachytherapy is a common outpatient procedure for the treatment of prostate cancer. Whereas long-term morbidity and toxicities are widely published, rates of short-term complications leading to hospital revisits have not been well described. MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Belinda, Kirshenbaum, Eric J., Blackwell, Robert H., Gange, William S., Saluk, Jennifer, Zapf, Matthew A.C., Kothari, Anai N., Flanigan, Robert C., Gupta, Gopal N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664312/
https://www.ncbi.nlm.nih.gov/pubmed/31384608
http://dx.doi.org/10.1016/j.prnil.2018.03.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664312/
https://www.ncbi.nlm.nih.gov/pubmed/31384608
http://dx.doi.org/10.1016/j.prnil.2018.03.003

Ejemplares similares